Nino Rainusso

Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

Nabil Ahmed, Vita S. Brawley, Meenakshi Hegde et al. · Journal of Clinical Oncology · 2015 · 979 citations

Medicine, Immunology, Oncology +17

T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma

Kevin Chow, Swati Naik, Sunitha Kakarla et al. · Molecular Therapy · 2012 · 248 citations · Full text

Life Sciences, Immunology, Oncology +17

TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer

Tiara T. Byrd, Kristen Fousek, Antonella Pignata et al. · Cancer Research · 2017 · 156 citations · Full text

Medicine, Immunology, Oncology +17

Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma

Nino Rainusso, Vita S. Brawley, Alexia Ghazi et al. · Cancer Gene Therapy · 2011 · 119 citations

Medicine, Cancer Biology, Oncology +13

Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma

Motonari Nomura, Nino Rainusso, Yi‐Chien Lee et al. · JNCI Journal of the National Cancer Institute · 2019 · 99 citations · Full text

Medicine, Oncology, Pharmacology +12